Immunocore Holdings Plc ADR
(IMCR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -132,710 | N/A | N/A |
| Depreciation Amortization | 11,764 | N/A | N/A |
| Accounts receivable | 2,334 | N/A | N/A |
| Accounts payable and accrued liabilities | 12,700 | N/A | N/A |
| Other Working Capital | -12,887 | N/A | N/A |
| Other Operating Activity | -10,649 | 0 | 0 |
| Operating Cash Flow | $-129,447 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -5,103 | N/A | N/A |
| Purchase Sale Intangibles | -253 | N/A | N/A |
| Other Investing Activity | -180 | 0 | 0 |
| Investing Cash Flow | $-5,283 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 76,488 | N/A | N/A |
| Other Financing Activity | -6,096 | 0 | 0 |
| Financing Cash Flow | $70,392 | $N/A | $N/A |
| Exchange Rate Effect | -42 | N/A | N/A |
| Beginning Cash Position | 158,827 | N/A | N/A |
| End Cash Position | 94,447 | N/A | N/A |
| Net Cash Flow | $-64,380 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -129,447 | N/A | N/A |
| Capital Expenditure | -5,207 | N/A | N/A |
| Free Cash Flow | -134,654 | 0 | 0 |